In addition, enzyme expression was found to be directly related with important prognostic parameters, such as Breslow thickness, Clark level, regression, mitoses, lymph node metastases, pT, and pathological stage, thus suggesting a potential role for PON2 as a biomarker for melanoma aggressiveness. The gene discussed is PON2; the disease is metastatic malignant neoplasm in the lymph nodes.